GNPAT
Basic information
Region (hg38): 1:231241207-231277973
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 29.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
ENST00000366647.9 | ENSP00000355607.4 | 16 | yes | - |
ENST00000416000.1 | ENSP00000411640.1 | 13 | - | - |
ENST00000436239.5 | ENSP00000402811.1 | 6 | - | - |
ENST00000644483.1 | ENSP00000496537.1 | 4 | - | - |
Phenotypes
GenCC
Source:
- glyceronephosphate O-acyltransferase deficiency (Definitive), mode of inheritance: AR
- rhizomelic chondrodysplasia punctata type 2 (Strong), mode of inheritance: AR
- rhizomelic chondrodysplasia punctata type 2 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Rhizomelic chondrodysplasia punctata, type 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 1405476; 8466247; 7530787; 7541833; 9536089; 20583171; 21990100 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (438 variants)
- Rhizomelic_chondrodysplasia_punctata_type_2 (103 variants)
- Inborn_genetic_diseases (77 variants)
- not_specified (14 variants)
- GNPAT-related_disorder (4 variants)
- Rhizomelic_chondrodysplasia_punctata (2 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNPAT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014236.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 147 | 2 | 156 | ||
| missense | 1 | 2 | 140 | 10 | 2 | 155 |
| nonsense | 6 | 12 | 18 | |||
| start loss | 0 | |||||
| frameshift | 15 | 18 | 1 | 34 | ||
| splice donor/acceptor (+/-2bp) | 2 | 10 | 6 | 18 | ||
| Total | 24 | 42 | 154 | 157 | 4 |
Highest pathogenic variant AF is 0.000010261504
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| GNPAT | protein_coding | protein_coding | ENST00000366647 | 16 | 36767 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125727 | 0 | 21 | 125748 | 0.0000835 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.674 | 316 | 352 | 0.899 | 0.0000187 | 4484 |
| Missense in Polyphen | 89 | 111.73 | 0.79656 | 1425 | ||
| Synonymous | -0.0637 | 125 | 124 | 1.01 | 0.00000634 | 1282 |
| Loss of Function | 4.19 | 8 | 34.6 | 0.231 | 0.00000181 | 434 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000181 | 0.000181 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.0000465 | 0.0000462 |
| European (Non-Finnish) | 0.0000968 | 0.0000967 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Disease
- DISEASE: Rhizomelic chondrodysplasia punctata 2 (RCDP2) [MIM:222765]: A form of rhizomelic chondrodysplasia punctata, a disease characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe mental retardation with spasticity. {ECO:0000269|PubMed:11152660, ECO:0000269|PubMed:21990100, ECO:0000269|PubMed:9536089}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Peroxisome - Homo sapiens (human);Plasmalogen Synthesis;Triacylglyceride Synthesis;Metabolism of lipids;Metabolism of proteins;Metabolism;Peroxisomal protein import;Glycerophospholipid metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Plasmalogen biosynthesis;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.265
Intolerance Scores
- loftool
- 0.328
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.11
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.977
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein targeting to peroxisome;fatty acid metabolic process;phosphatidic acid biosynthetic process;synapse assembly;response to nutrient;ether lipid biosynthetic process;phospholipid biosynthetic process;cerebellum morphogenesis;paranodal junction assembly;response to drug;response to starvation;membrane organization;response to fatty acid
- Cellular component
- peroxisome;peroxisomal membrane;peroxisomal matrix;cytosol;membrane;mitochondrial membrane
- Molecular function
- signaling receptor binding;glycerone-phosphate O-acyltransferase activity;palmitoyl-CoA hydrolase activity